Migraine-Associated Otalgia: An Underappreciated Entity

被引:2
|
作者
Sussman, Sarah [1 ]
Zimmerman, Zachary [2 ]
Chishom, Taylor [3 ]
Reid, Lauren [4 ]
Seyyedi, Mohammad [1 ]
机构
[1] Georgia Augusta Univ, Dept Otolaryngol, Med Coll, 1120 15th ST,BP-4109, Augusta, GA 30912 USA
[2] Northwestern Univ, Dept Otolaryngol, Chicago, IL USA
[3] Virginia Commonwealth Univ Hlth, Dept Plast Surg, Richmond, VA USA
[4] Univ Tennessee, Dept Otolaryngol, Hlth Sci Ctr, Memphis, TN USA
来源
JOURNAL OF AUDIOLOGY AND OTOLOGY | 2022年 / 26卷 / 02期
关键词
Otalgia; Migraine; Migraine disorders; Secondary otalgia; PREVALENCE; DISEASE;
D O I
10.7874/jao.2021.00465
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background and Objectives: Otalgia can be primary/otogenic or secondary as a referred pain from another site, which can be difficult to establish owing to various causes and the complex innervation of the ear. In our center, we observed a large group of patients with unexplained otalgia that had a higher prevalence of migraine. We hypothesized that migraine may cause secondary otalgia. This study then aimed to determine the prevalence of migraine-associated otalgia and evaluate the efficacy of migraine treatment. Subjects and Methods: This 2-year retrospective study was conducted at a busy otology clinic. Patients were identified using diagnostic codes corresponding to otalgia. The prevalence of migraine-associated otalgia was determined, and the efficacy of migraine treatment was evaluated in these patients. The interventions included prophylactic and abortive migraine treatments. Statistical analysis was conducted to compare between the pre- and post-treatment symptoms. Results: A total of 208 patients with otalgia were identified. Sixty-four out of ninety patients with unexplained otalgia met the criteria for migraine; of them, 30 patients had an adequate follow-up and were thus included in the evaluation of treatment efficacy. Otalgia improved in 87% of the patients who received migraine treatment. After treatment, the mean pain score and headache frequency significantly decreased from 7 to 2 and from 27 to 9 days per month, respectively (p<0.001). Conclusions: Migraine should be considered as a source of secondary otalgia, and patients should receive treatment as they often respond to migraine treatment.
引用
收藏
页码:90 / 96
页数:7
相关论文
共 50 条
  • [31] Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness
    Bikhazi, P
    Jackson, C
    Ruckenstein, MJ
    AMERICAN JOURNAL OF OTOLOGY, 1997, 18 (03): : 350 - 354
  • [32] Remission of Migraine-associated Allodynia After Intravenous Magnesium
    Xu, F. L.
    Sahai-Srivastava, S.
    Cesar, P-H
    HEADACHE, 2017, 57 : 136 - 136
  • [33] In reference to what are the diagnostic criteria for migraine-associated vertigo?
    Brookler, Kenneth H.
    LARYNGOSCOPE, 2014, 124 (04): : E148 - E148
  • [34] Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine
    McAllister, Peter
    Kudrow, David
    Cady, Roger
    Hirman, Joe
    Ettrup, Anders
    CEPHALALGIA, 2022, 42 (10) : 1005 - 1012
  • [35] Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine
    McAllister, P.
    Kudrow, D.
    Cady, R.
    Hirman, J.
    Ettrup, A.
    HEADACHE, 2021, 61 : 142 - 143
  • [36] High migraine-associated disability in previously undiagnosed migraine patients in primary care
    Lipton, RB
    Dodick, D
    Hettiarachchi, J
    CEPHALALGIA, 2004, 24 (09) : 803 - 803
  • [37] Almotriptan reduces the incidence of migraine-associated symptoms: A pooled analysis
    Cady, R
    HEADACHE, 2002, 42 : S26 - S31
  • [38] Cognitive impairment and quality of life in patients with migraine-associated vertigo
    Wang, N.
    Huang, H-L
    Zhou, H.
    Yu, C-Y
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (23) : 4913 - 4917
  • [39] Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan
    Allais, Gianni
    Acuto, Giancarlo
    Benedetto, Chiara
    D'Andrea, Giovanni
    Grazzi, Licia
    Manzoni, Gian Camillo
    Moschiano, Franca
    d'Onofrio, Florindo
    Valguarnera, Fabio
    Bussone, Gennaro
    NEUROLOGICAL SCIENCES, 2010, 31 : 115 - 119
  • [40] Soluble guanylyl cyclase is a critical regulator of migraine-associated pain
    Ben Aissa, Manel
    Tipton, Alycia F.
    Bertels, Zachariah
    Gandhi, Ronak
    Moye, Laura S.
    Novack, Madeline
    Bennett, Brian M.
    Wang, Yueting
    Litosh, Vladislav
    Lee, Sue H.
    Gaisina, Irina N.
    Thatcher, Gregory R. J.
    Pradhan, Amynah A.
    CEPHALALGIA, 2018, 38 (08) : 1471 - 1484